CIK 0001755237 · Non-accelerated filer<br>Smaller reporting company
Korsana Biosciences, Inc.
Sign in to watch- Ticker
- KRSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 831895370
- Phone
- (781) 516-2325
- Business address
- 203 CRESCENT STREET, BLDGS. #3/3A/4, SUITE 503, WALTHAM, MA, 02453
- Former names
- Cyclerion Therapeutics, Inc.
- 10-K/A Report 10-K/A
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- 8-K Event Shareholder vote results
- EFFECT Other Notice of Effectiveness
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 4 of 20 · 393 filings